| 1 |
35264157 | Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling. | 2022 Mar 9 |
1 |
| 2 |
35270034 | A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer. | 2022 Mar 7 |
1 |
| 3 |
33534964 | PD-0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance. | 2021 Mar |
1 |
| 4 |
33676835 | Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib. | 2021 Aug |
1 |
| 5 |
34036394 | CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma. | 2021 Jul |
8 |
| 6 |
32229099 | Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms. | 2020 Jul |
2 |
| 7 |
32418994 | CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms. | 2020 Aug |
2 |
| 8 |
33061853 | Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer. | 2020 |
2 |
| 9 |
30242024 | CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status. | 2019 Jan 1 |
2 |
| 10 |
31727874 | Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma. | 2019 Nov 14 |
1 |
| 11 |
26575528 | Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines. | 2016 Jan |
1 |
| 12 |
26993269 | CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma. | 2016 Mar 18 |
2 |
| 13 |
25703099 | miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma. | 2015 Nov |
2 |
| 14 |
24338822 | CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. | 2014 Feb 15 |
1 |
| 15 |
21592546 | The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. | 2011 Aug |
2 |
| 16 |
18942709 | Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity. | 2009 Jan 15 |
1 |